INGEMM, IdIPAZ, CIBERER, Hospital Universitario La Paz, Madrid, Spain.
Clin Genet. 2013 Dec;84(6):566-71. doi: 10.1111/cge.12103. Epub 2013 Mar 11.
Pelizaeus-Merzbacher disease (PMD) is caused in most cases by either duplications or point mutations in the PLP1 gene. This disease, a dysmyelinating disorder affecting mainly the central nervous system, has a wide clinical spectrum and its causing mutations act through different molecular mechanisms. Eighty-eight male patients with leukodystrophy were studied. PLP1 gene analysis was performed by the Multiplex Ligation-dependent Probe Amplification technique and DNA sequencing, and, in duplicated cases of PLP1, gene dosage was completed by using array-CGH. We have identified 21 patients with mutations in the PLP1 gene, including duplications, short and large deletions and several point mutations in our cohort. A customized array-CGH at the Xq22.2 area identified several complex rearrangements within the PLP1 gene region. Mutations found in the PLP1 gene are the cause of PMD in around 20% of the patients in this series.
佩利兹-梅茨巴赫病(PMD)在大多数情况下是由 PLP1 基因的重复或点突变引起的。这种疾病是一种影响中枢神经系统的脱髓鞘疾病,具有广泛的临床谱,其致病突变通过不同的分子机制起作用。对 88 名男性白质营养不良患者进行了研究。通过多重连接依赖性探针扩增技术和 DNA 测序进行 PLP1 基因分析,在 PLP1 重复的情况下,通过使用阵列-CGH 完成基因剂量测定。我们在我们的队列中发现了 21 名 PLP1 基因突变的患者,包括重复、短和大片段缺失以及几个点突变。Xq22.2 区域的定制阵列-CGH 鉴定了 PLP1 基因区域内的几个复杂重排。在 PLP1 基因中发现的突变是该系列中约 20%的 PMD 患者的病因。